SB 5498
SignedSenate
Contraceptive coverage
Concerning contraceptive coverage.
How does a bill become law?
- Introduced: The bill is filed and assigned a number.
- Committee: A subject-matter committee holds hearings, takes public testimony, and decides whether to advance the bill.
- Floor Vote: The full chamber (House or Senate) debates and votes on the bill.
- Opposite Chamber: The bill repeats the committee and floor vote process in the other chamber.
- Governor: The Governor reviews the bill and decides whether to sign or veto it.
- Signed: The bill has been signed into law.
AI Analysis
This bill expands access to contraception by requiring health plans to cover a full 12-month supply of contraceptive drugs in a single refill, and to allow on-site dispensing at provider offices. It also clarifies which drugs are covered and limits how plans can restrict refills near year-end.
- Requires health plans that cover contraceptive drugs to allow enrollees to receive a 12-month supply in a single refill (unless the enrollee or provider requests less).
- Requires plans to allow enrollees to receive contraceptive drugs on-site at the provider’s office, if the provider offers that service.
- Permits plans to limit refills in the last quarter of the plan year only if a full 12-month supply was already dispensed earlier that year.
- Clarifies that 'contraceptive drugs' include all FDA-approved medications used to prevent pregnancy—including oral, patch, and vaginal forms.
Who is affected
- People with private health insurance plans that cover contraceptives — People who use prescription contraception (e.g., birth control pills, patches, rings, or injections) will be able to get a full 12-month supply in a single refill, reducing the need for frequent visits or refills—unless their provider recommends otherwise or they request less.
- Health insurance companies and managed care organizations — Health plans and insurers must update their policies to allow 12-month contraceptive supplies and on-site dispensing where available, and follow clinical guidelines to ensure safe access.
- Healthcare providers and pharmacies — Clinicians and pharmacies must follow updated billing and dispensing rules, including allowing patients to receive contraceptives during office visits if offered, and adhering to clinical guidelines for appropriate prescribing.
Pro/Con Analysis
Stronger case for benefits
Potential Benefits (5)
Allowing a 12-month supply in a single refill significantly reduces out-of-pocket time and transportation costs, especially for low-income, rural, disabled, or transit-limited patients—reducing unintended pregnancy risk and improving adherence.
HealthcarePeopleRef: Sec. 1(1)On-site dispensing at provider offices increases access for patients in areas with pharmacy deserts or for those who face barriers to visiting separate pharmacies (e.g., caregivers, people with disabilities, unhoused individuals).
HealthcarePeopleRef: Sec. 1(1)Standardizing coverage of all FDA-approved contraceptive drugs—including oral, patch, and vaginal forms—reduces prior authorization hurdles and formulary restrictions that disproportionately affect low-income and marginalized patients.
HealthcarePeopleRef: Sec. 1(1)The bill is expected to generate minimal net fiscal impact due to administrative simplification and potential reductions in unintended pregnancy-related healthcare costs—benefiting public health systems and state Medicaid (Apple Health) programs.
HealthcarePeopleRef: Fiscal Impact SummaryThe year-end refill limitation is narrowly scoped and only applies if a full 12-month supply was already dispensed—preventing overuse while preserving access for most patients, and aligning with clinical best practices for chronic medication management.
HealthcarePeopleRef: Sec. 1(2)
Potential Concerns (4)
The requirement to allow on-site dispensing may increase administrative complexity for small or rural clinics that lack infrastructure (e.g., storage, staffing, billing systems) to dispense contraceptives directly, potentially leading to inconsistent access depending on provider capability.
HealthcareRef: Sec. 1(1)While the bill allows a 12-month supply, it does not require plans to cover the full cost without copays or deductibles—plans may still apply cost-sharing, which could deter use among low-income enrollees despite increased access.
HealthcareRef: Sec. 1(1)The year-end refill limitation creates a potential gap in coverage for patients who receive a 12-month supply early in the year and must wait until the next plan year for a refill—potentially disrupting continuity of care for those with unstable housing or limited transportation.
HealthcareRef: Sec. 1(2)The definition of 'contraceptive drugs' excludes non-FDA-approved methods (e.g., some compounded hormones, off-label uses), limiting coverage to FDA-approved products only—potentially excluding some patients who rely on alternative formulations for medical or personal reasons.
HealthcareRef: Sec. 1(3)
Who Is Most Affected
Low-income and working-class women of reproductive age benefit significantly: reduced out-of-pocket time/costs, improved adherence, and greater autonomy over reproductive timing—especially for those without reliable transportation or childcare.
Rural and underserved communities benefit from on-site dispensing and reduced need for pharmacy visits, mitigating geographic and infrastructure barriers to contraception access.
Health plans may see modest administrative savings from simplified refill processes, but face no major cost increases given alignment with federal requirements and minimal fiscal impact estimates.
Clinicians (especially in primary care, OB/GYN, and family planning) gain flexibility to provide immediate, high-efficacy contraception during visits, improving continuity of care—but may face minor billing or inventory adjustments.
Pharmacies may see reduced volume of contraceptive refills, but the bill explicitly preserves their role—no major negative impact expected, and some may benefit from increased on-site dispensing partnerships with providers.